Pharmaceutical raw materials backed by CTD-DMF!
Our pharmaceutical raw materials are manufactured in facilities that have been inspected for pharmaceuticals in accordance with cGMP and are backed by CTD-DMF. Products created under excellent technology related to plant-derived ingredients include a wide range such as Ajmaline, Boldine, Colchicine USP, and Galantamine Hydrobromide. We will introduce them categorized as "isolated or semi-synthetic refined products" and "standardized, refined, or other characteristic dry extracts." 【Features】 ■ Backed by CTD-DMF ■ Manufactured in facilities that have been inspected for pharmaceuticals ■ Active ingredients derived from edible and medicinal plants *For more details, please refer to the catalog or feel free to contact us.
Inquire About This Product
basic information
【Lineup】 ■ Isolated or semi-synthetic purified products - Ajmaline - Boldine - Colchicine EUR. PH. - Colchicine USP - Plajmaline, etc. ■ Standardized, purified, or other characteristic dry extracts - European Isopyrum - Vireal - Mirtosian-Bilberry - Bold, etc. ■ Characteristic, standardized oily and soft extracts - Prunus Select Pigeon - Chinese Rhubarb water-extracted soft extract - Saw Palmetto - Saw Palmetto alcohol-extracted extract, etc. *For more details, please refer to the catalog or feel free to contact us.
Price range
Delivery Time
Applications/Examples of results
For more details, please refer to the catalog or feel free to contact us.
Company information
Our company is one of the world's leading firms in discovering, developing, and producing plant-derived active ingredients used in the cosmetics industry. Indena, a private company based in Italy, employs around 800 people, of which 10% are full-time research staff, and operates cultivation, manufacturing, and sales in over 70 countries worldwide. The success of Indena is attributed to its research efforts, which include pharmacological testing of medicinal plants, the discovery of new active ingredients, and the development of cutting-edge extraction and purification processes for product production. Currently, we are also focusing on the industrial production of high-quality standardized plant extracts, which are important raw materials for health foods. In fact, we produce standardized extracts from edible plants traditionally believed to have medicinal effects and from plants with proven pharmacological effects.
![[Column] Management Strategies for Starting Materials in Active Pharmaceutical Ingredients](https://image.mono.ipros.com/public/product/image/3e5/2000710289/IPROS06292587954207697823.png?w=280&h=280)
